Navigation Links
Experiments reveal unexpected activity of fuel cell catalysts
Date:12/13/2007

UPTON, NY -- Researchers at the U.S. Department of Energys Brookhaven National Laboratory have unveiled important details about a class of catalysts that could help improve the performance of fuel cells. With the goal of producing clean hydrogen for fuel cell reactions in mind, the researchers determined why two next-generation catalysts including gold, cerium, titanium, and oxygen nanomaterials exhibit very high activity. Their results will be published online in the December 14, 2007, edition of the journal Science.

Fuel cells combine hydrogen and oxygen without combustion to produce direct electrical power and water. They are attractive as a source of power for transportation applications because of their high energy efficiency, the potential for using a variety of fuel sources, and their zero emissions. However, a major problem facing this technology is that the hydrogen-rich materials feeding the reaction often contain carbon monoxide (CO), which is formed during hydrogen production. Within a fuel cell, CO poisons the expensive platinum-based catalysts that convert hydrogen into electricity, deteriorating their efficiency over time and requiring their replacement.

Fuel cell reactions are very demanding processes that require very pure hydrogen, said Brookhaven chemist Jose Rodriguez. You need to find some way to eliminate the impurities, and thats where the water-gas shift reaction comes into play.

The water-gas shift (WGS) reaction combines CO with water to produce additional hydrogen gas and carbon dioxide. With the assistance of proper catalysts, this process can convert nearly 100 percent of the CO into carbon dioxide. Rodriguezs group, which includes researchers from Brookhavens chemistry department, the Center for Functional Nanomaterials (CFN), and the Central University of Venezuela, studied two next-generation WGS nanoscale catalysts: gold-cerium oxide and gold-titanium oxide.

These nanomaterials have recently
'/>"/>

Contact: Karen McNulty Walsh
kmcnulty@bnl.gov
631-344-8350
DOE/Brookhaven National Laboratory
Source:Eurekalert

Page: 1 2

Related biology technology :

1. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
2. Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007
3. New Data Reveal Ethnicity May Play Role in Weight Loss Decisions
4. New paper reveals nanoscale details of photolithography process
5. Stem Cell Agency Finally Reveals Institutions Involved in Conflict Problem
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests
8. Celator(R) Pharmaceuticals Study Shows CPX-571 Maintains Synergistic Ratio of Irinotecan and Cisplatin to Improve Anti-tumor Activity
9. Brostallicin Trial Data Demonstrates Encouraging Anti-tumor Activity in Patients With Chemotherapy-Resistant Cancers
10. Using catalysts to stamp nanopatterns without ink

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...swire-FirstCall/ -- ,, 3Q09 Corporate Highli....U. Marketing Authorization to Astellas Pharma Eur... readiness activities Expanded management team to... Director, Commercial Operations Appointed Bradfo...ttee chairman , Upcoming 2009 Milestones: ...
(Date:11/6/2009)...tCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:...ced updated results from a Phase II study of intra...tatic to the lung in a poster presentation at the ...ting held in Miami Beach, Florida, from November 5...ase II Study of Intravenous REOLYSIN (Wild-type Re...
(Date:11/6/2009)...or Arrowhead’s 2010 Personalized Medicine Pa...on February 22-24, 2010 in Philadelphia, has been ...ghlight key issues in forming partnerships and eng... , Minneapolis, MN (PRWEB)...o;s 2010 Personalized Medicine Partnerships Confe...
(Date:11/5/2009)...swire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) ...d quarter ended September 30, 2009. GenVec reporte... the three months ended September 30, 2009 compare...in the comparable quarter of 2008. For the nine mo...as $14.1 million ($0.15 per share), compared to a ...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
... April 20 Santaris Pharma announced today,promisi...f microRNA-targeted,therapeutics against cancer de...leic Acid (LNA) Drug Platform. In both in vitro an... LNA-antimiR(R),s demonstrated outstanding,recogni...s due to their high,specificity and affinity. The ...
...nowned Physicians Join World Class Group of Adviso...nc. today announced the expansion of its Clinical ...FIDSA, and G. Ralph Corey, MD, as the sixth and se...ht leaders. Dr. Batts is a Professor of Medicine ...fectious Diseases at its Kalamazoo Campus. Dr. Co...
...ublication in Nature Photonics , a joint team of ...l Physics Center DIPC, Centro de Fsica de Material...rd University (USA) and the Max Planck Institute o...vative method for controlling light on the nanosca...y technology. The method opens the door for target...
Other Biology Technology:LNA-Based RNA oligonucleotides Potently Inhibit Cancer microRNAs 2Trius Appoints Don Batts and Ralph Corey to Clinical Advisory Board 2Bridging the gap in nanoantennas 2Bridging the gap in nanoantennas 3
(Date:11/4/2009)... received more than $10 million in research grants... stimulus program, bringing thetotal amount of sti...llion. Thirty-three projects achieved stimulus fu...her. , "The university has thoughtfully undertak...arly excellence to federal agency priorities. Thr...
(Date:11/4/2009)...FirstCall/ -- Aware, Inc. (Nasdaq: AWRE ), a lead...s software, today reported financial results for i..., Michael Tzannes, Aware,s Chairman and Chief Exec...an agreement to sell our DSL and home networking p...r company being spun out of Infineon. This transa...
(Date:11/4/2009)...obal Rainmakers, Inc., an intellectual property ho...ay announced that the company has exited its "stea...e its suite of technologies designed to leverage c...ring the past four years, the company has spent te...series of core--but expandable--technologies built...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3National League of Cities Commends President and Congress on Work Towards Health Care Reform 53390 1National League of Cities Commends President and Congress on Work Towards Health Care Reform 53390 2Blood Transfusions Not Linked to Long Term Problems 53386 1NFL Cardinals Wide Receiver Larry Fitzgerald Promotes Vision Therapy 53382 1NFL Cardinals Wide Receiver Larry Fitzgerald Promotes Vision Therapy 53382 2NFL Cardinals Wide Receiver Larry Fitzgerald Promotes Vision Therapy 53382 3NFL Cardinals Wide Receiver Larry Fitzgerald Promotes Vision Therapy 53382 4
...utant mouse that is highly susceptible to mammary ...ential link between genetic defects in DNA replica...ains a mutation in a gene essential for replicatin...ate of flawed copies of genetic material, leading ...in Nature Genetics online (and upcoming in the Dec...
...d analysis of fifty years of remotely sensed image...on in the size and number of more than 10,000 pond... Fairbanks scientists and published this week in t... these landscape-level changes in arctic ponds are...and may have profound effects on climate and wildl...
...ly overweight people -- consume up to 50 percent m...ck foods than when they eat the regular versions, ...panion study finds, when food labels show serving ...r chocolates, normal-weight people tend not to ove... a world of fat-free, carb-free and sugar-free pro...
Other Biology News:Mutant mouse provides insights into breast cancer 2Shrinking ponds signal warmer, dryer Alaska 2
...rrays designed for genome-wide microRNA expression...Paraflo microfluidic on-chip synthesis platform. T...rehensive microRNA Expression Profiling Service. ...ntains all known virus microRNAs (98 unique mature...
... forefront of Agilent analytical solutions is the ...ea networking (LAN) allows you to share business a...rmed decision making. Just as its 6890 GC predeces...nce needed for research and method development in ...
HCT Plus from Bruker Daltonics
RF-5301 Fluorescence Spectrophotometer from Shimadzu
Biology Products: